Is there any role for the Hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?

Sara De Carolis, Antonio Lanzone, Angela Botta, Elvira Di Pasquo, Gelsomina Del Sordo, Maria Pia De Carolis

Risultato della ricerca: Contributo in rivistaArticolo in rivista

24 Citazioni (Scopus)

Abstract

The best therapy regimen for refractory obstetrical antiphospholipid syndrome remains to be determined. Additional treatments with steroids, plasma exchanges and immunoglobulins failed to show any beneficial effect. We present a case of a woman who had a better pregnancy outcome after the administration of hydroxychloroquine (HCQ) as additional treatment. Furthermore, we highlighted that HCQ was able to dramatically reduce the antiphospholipid antibodies levels.
Lingua originaleEnglish
pagine (da-a)760-762
Numero di pagine3
RivistaAUTOIMMUNITY REVIEWS
DOI
Stato di pubblicazionePubblicato - 2015

Keywords

  • Hydroxychloroquine
  • obstetrical antiphospholipid syndrome

Fingerprint Entra nei temi di ricerca di 'Is there any role for the Hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?'. Insieme formano una fingerprint unica.

Cita questo